- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/14 - Peptides containing saccharide radicalsDerivatives thereof
Patent holdings for IPC class A61K 38/14
Total number of patents in this class: 1017
10-year publication summary
107
|
107
|
96
|
97
|
103
|
102
|
86
|
81
|
64
|
27
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Yeda Research and Development Co. Ltd. | 1329 |
16 |
The Regents of the University of California | 19839 |
14 |
Theriva Biologics, Inc. | 83 |
12 |
Purdue Research Foundation | 3571 |
11 |
Insmed Incorporated | 231 |
10 |
The Scripps Research Institute | 1346 |
10 |
Hikma Pharmaceuticals USA Inc. | 158 |
10 |
Melinta Therapeutics, Inc. | 50 |
9 |
Protokinetix, Inc. | 17 |
9 |
Azurity Pharmaceuticals, Inc. | 209 |
9 |
City of Hope | 982 |
8 |
Immunomedics, Inc. | 267 |
8 |
Centre National de La Recherche Scientifique | 10350 |
7 |
Northwestern University | 3366 |
7 |
The Research Foundation for The State University of New York | 1608 |
7 |
Salix Pharmaceuticals, Inc. | 81 |
7 |
University of Memphis Research Foundation | 112 |
7 |
Scidose Pharma LLC | 7 |
7 |
Massachusetts Institute of Technology | 10019 |
6 |
Cedars-Sinai Medical Center | 1142 |
6 |
Other owners | 837 |